Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase NA 1

Status

Unknown 5Recruiting 5Active not recruiting 4Terminated 3Completed 2

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Gastrointestinal 3Gynecologic 1Genitourinary 1Breast 1

Conditions

Breast Neoplasms 1774Neoplasms 1501Carcinoma, Non-Small-Cell Lung 1043Prostatic Neoplasms 957Colorectal Neoplasms 878Lung Neoplasms 800Pancreatic Neoplasms 572Carcinoma, Hepatocellular 542Leukemia, Myeloid, Acute 541Stomach Neoplasms 512Ovarian Neoplasms 507Neoplasm Metastasis 496Multiple Myeloma 495Recurrence 413Melanoma 386Squamous Cell Carcinoma of Head and Neck 370Brain Neoplasms 362Uterine Cervical Neoplasms 361Head and Neck Neoplasms 355Esophageal Neoplasms 312Precursor Cell Lymphoblastic Leukemia-Lymphoma 310Lymphoma 305Endometrial Neoplasms 304Triple Negative Breast Neoplasms 299Glioblastoma 298Rectal Neoplasms 280Urinary Bladder Neoplasms 264Sarcoma 264Hematologic Neoplasms 264Colonic Neoplasms 254

Interventions

Paclitaxel 1Famotidine 1Diphenhydramine 1Dexamethasone 1DNA Fingerprinting 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Adenocarcinoma, Mucinous × Clear all
NCT05947838 2026-05-18

A Prospective Feasibility Study Using ctDNA to Tailor Neoadjuvant Chemotherapy for Patients With Colorectal or Appendiceal Adenocarcinoma

M.D. Anderson Cancer Center

Phase NA Recruiting
48 enrolled

Adenocarcinoma, Mucinous

NCT07587268 2026-05-14

Molecular Profiling for Risk Stratification in Appendiceal Cancer

City of Hope Medical Center

Recruiting
400 enrolled
Gastrointestinal

Appendiceal Neoplasms, Adenocarcinoma, Mucinous

NCT06207305 2026-01-13

A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma

M.D. Anderson Cancer Center

Phase 1/2 Recruiting
39 enrolled

Adenocarcinoma, Mucinous

NCT06399757 2026-01-07

A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors

Apollo Therapeutics Ltd

Phase 1/2 Recruiting
100 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Adenocarcinoma, Mucinous, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma, Triple Negative Breast Neoplasms

NCT05734430 2025-04-18

GAP

Vanderbilt-Ingram Cancer Center

Recruiting
700 enrolled
Gastrointestinal

Appendiceal Neoplasms, Adenocarcinoma, Mucinous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡